Patricia Imbach‐Weese

Author

Novartis (Switzerland)

Also Known As

Patricia Imbach-Weese, Patricia Imbach‐Weese

Publications

630

Citations

H-Index

Concepts

All Affiliations

Novartis (Switzerland)Novartis Institutes for BioMedical Research

About

Patricia Imbach‐Weese is an author at Novartis (Switzerland) specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	600
2	Natural Sciences	4	4	112
3	Biochemistry	4	4	112
4	Chemical Biology	2	2	74
5	Cell Biology	1	1	28

Patricia Imbach‐Weese

Publications

612

Citations

H-Index

Page 1

	Year	Citations
Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation Pascal Furet, Vito Guagnano, Robin A. Fairhurst, Bioorganic & Medicinal Chemistry Letters MedicineReceptor Tyrosine KinaseImmunologyAntiviral Drug DevelopmentPharmacotherapy	2013	460
The First Class of Small Molecules Potently Disrupting the YAP‐TEAD Interaction by Direct Competition Pascal Furet, Vincent Bordas, Mickaël Le Douget, ChemMedChem Drug TargetYap-tead InteractionDirect CompetitionMolecular BiologyChemical Biology	2022	42
Discovery of New Binders for DCAF1, an Emerging Ligase Target in the Targeted Protein Degradation Field Anna Vulpetti, Philipp Holzer, Niko Schmiedeberg, ACS Medicinal Chemistry Letters Protein AssemblyMolecular BiologyWd40 Repeat DomainChemistryChemical Biology	2023	32
Podocyte EphB4 signaling helps recovery from glomerular injury Monika Wnuk, Ruslan Hlushchuk, Mathilde Janot, Kidney International InflammationGlomerulonephritisRenal FunctionMolecular PhysiologyPodocyte Ephb4	2012	28
Identification and optimisation of a 4′,5-bisthiazole series of selective phosphatidylinositol-3 kinase alpha inhibitors Robin A. Fairhurst, Patricia Imbach‐Weese, Marc Gerspacher, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryBiochemistryMedicineNatural Sciences	2015	21
Identification and optimisation of 4,5-dihydrobenzo[1,2-d:3,4-d]bisthiazole and 4,5-dihydrothiazolo[4,5-h]quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors Robin A. Fairhurst, Marc Gerspacher, Patricia Imbach‐Weese, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryMedicinal ChemistryBiochemistryMedicineNatural Sciences	2015	17
Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase Inhibitor Robin A. Fairhurst, Pascal Furet, Patricia Imbach‐Weese, Journal of Medicinal Chemistry	2022	12

Page 1